I am pleased to announce that we’ve just rolled out a new digital platform that will elevate Ophthalmology Management and The Ophthalmic ASC by showcasing our editorial content and enhancing your reading experience. Conexiant is designed to serve as a resource for clinical connectivity and learning, fostering a unified community that diminishes the divide in accessing interdisciplinary content.

Why Conexiant? Our industry is evolving, and so are we. Over the last 25 years, we have taken what we learned from various interactions, ranging from studying healthcare provider behaviors across multiple platforms and content types, to gathering insights from our in-person events, to conducting regular surveys and garnering feedback from our readers. We also work closely with our partners and editorial boards to ensure a holistic understanding of the environment. We’ve found that our audience seeks a reliable source to consume trusted clinical information, earn continuing education credits, stay up to date with the latest specialty-specific news, and introduce new ways to connect with peers, all in one place.

These insights have guided us to create a new network that will present enriched content, elevating the topics that we feature in our issues with machine-learning recommendations. Conexiant will deliver articles from The Ophthalmic ASC along with breaking news and conference coverage, access to the latest FDA approvals and updates, and much more. This positions The Ophthalmic ASC at the forefront of the high-exposure healthcare provider audience we are engaging with.

Thank you for your continued support!

Sincerely, René Luthe, managing editor

The Ophthalmic ASC